Dr. Natinder Saini

Endocrinology/Diabetology

American Board of Pediatrics

Pediatric Endocrinology

Medical School: Dayanand Medical College And Hospital

Residency: New York Presbyterian Brooklyn Methodist

Fellowship: University of Michigan Medical School

Born and raised in New York, Dr. Natinder Saini is a board-certified pediatric endocrinologist. Her passion for the care of underserved communities took her to India where she completed medical school training at Dayanand Medical College in Punjab, India. She subsequently returned to New York to complete her pediatric residency at New York-Presbyterian Brooklyn Methodist Hospital and fellowship training at the University of Michigan-C.S. Mott Children’s Hospital. 

Dr. Saini believes in the principles of leaving no child behind and treating every family as one’s own. She is a strong advocate for access to equitable family-centered care and the need to address health disparities in the community.

Dr. Saini comes to CHKD with more than a decade of experience in developing interdisciplinary collaborations and partnerships, which helped to expand care for patients with Turner syndrome and those with endocrine complications of obesity in the previous communities where she served. She is committed to continuing these efforts, as well as developing a seamless conduit for pediatric to adult care transition.

In addition to her clinical interests, Dr. Saini thrives on the cultivation of medical education at all levels. This includes medical student and resident lectures and academic mentorship of undergraduate scientists through the Juvenile Diabetes Research Foundation (JDRF) scholars’ program.

Dr. Saini spends her free time listening and dancing to folk music with her husband and three daughters. She especially enjoys testing her culinary skills with global fusion delicacies.    

• Leptin receptor signaling in the brain
• Psychosocial impact of metabolic syndrome/Type 2 Diabetes on the pediatric population
• Non-canonical targets of GH signaling

• Pediatric endocrinology
• Neuro-endocrine health and complications of obesity
• Diabetes mellitus

• Cleveland Top Docs 2024
• Akron Top Docs 2021, 2022, 2023

1. Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation
   Inas H. Thomas, Natinder Saini, Amita Adhikari, Joyce M. Lee, Josephine Z. Kasa-Vubu. Pediatric Diabetes. 2009-11-0
   
   
2. Leptin action via LepR-b Tyr1077 contributes to the control of energy balance and female reproduction.
   Christa M. Patterson, Eneida C. Villanueva, Megan Greenwald-Yarnell, Michael Rajala, Ian E. Gonzalez, Natinder Saini, Justin Jones, Martin G. Myers Jr.   Molecular Metabolism. 2012-12-01
   
   
3. Severe hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in a 16 year old African-American male
   Michelle J. Gomez Cruz, Muhammad Jabbar, Natinder Saini, Donna S. Eng, Brandon Crawford Pediatric Diabetes. 2012-12-01
   
   
4. Esterase 1 is a Novel Transcriptional Repressor of Growth Hormone Receptor Gene Expression: A Unique Noncatalytic Role for a Carboxyesterase Protein. 
   
   
5. Jinhong Sun, P. Anil Kumar, Jamuna Thimmarayappa, Natinder Saini, Pooja Goel, Travis Maures, Chunxia Lu, Ram K. Menon, Molecular Endocrinology, Volume 25, Issue 8, 1 August 2011, Pages 1351–1363 
   
   
6. SAT-293 Novel Presentation Of A Heterozygous INSR Mutation And Markedly Elevated Testosterone Levels In A Pediatric Patient, A Case

Report

1. Jaime Haidet MD, Natinder Saini MD, Carrie Costin MD, Journal of Endocrine Society, 4/30/2019

• Pediatric Endocrine Society
• Endocrine Society
• American Diabetes Association
• Member of ODH Newborn Screening Program